Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 5, 2012, Pages 739-743

  Gecit, Ilhan ^a   Aslan, Mehmet ^a   Gunes, Mustafa ^a   Pirincci, Necip ^a   Esen, Ramazan ^a   Demir, Halit ^a   Ceylan, Kadir ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Bladder cancer; Malondialdehyde; Nitric oxide; Prolidase activity; Total antioxidant status

Indexed keywords

MALONALDEHYDE; NITRIC OXIDE; PROLINE DIPEPTIDASE; ANTIOXIDANT; DIPEPTIDASE;

ADULT; ARTICLE; BLADDER CANCER; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; AGED; BLADDER TUMOR; BLOOD; CARCINOMA; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVATION; LIPID PEROXIDATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

AGED; ANTIOXIDANTS; CARCINOMA; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIPEPTIDASES; ENZYME ACTIVATION; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; URINARY BLADDER NEOPLASMS;

EID: 84862289057     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1136-4     Document Type: Article

References (46)

1. Arioz DT, Camuzcuoglu H, Toy H, Kurt S, Celik H, Aksoy N (2009) Serum prolidase activity and oxidative status in patients with stage I endometrial cancer. Int J Gynecol Cancer 19:1244-1247
2. Batcioglu K, Mehmet N, Ozturk IC et al (2006) Lipid peroxidation and antioxidant status in stomach cancer. Cancer Invest 24:18-21 (Pubitemid 43247268)
3. Beevi SS, Rasheed MH, Geetha A (2007) Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin Chim Acta 375:119-132
4. Bukan N, Sözen S, Coskun U et al (2003) Serum interleukin-18 and nitric oxide activity in bladder carcinoma. Eur Cytokine Netw 14:163-167 (Pubitemid 37249236)
5. Camuzcuoglu H, Arioz DT, Toy H, Kurt S, Celik H, Aksoy N (2009) Assessment of preoperative serum prolidase activity in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 147(1):97-100
6. Cechowska-Pasko M, Pakła J, Wojtukiewicz MZ (2006) Enhanced prolidase activity and decreased collagen content in breast cancer tissue. Int J Exp Pathol 87:289-296 (Pubitemid 44049963)
7. Chinard FP (1952) Photometric estimation of proline and ornithine. J Biol Chem 199:91-95
8. Cui S, Reichner JS, Mateo RB, Albina JE (1994) Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or independent mechanisms. Cancer Res 54:2462-2467 (Pubitemid 24138741)
9. Duffy MJ (1996) Proteases as prognostic markers in cancer. Clin Cancer Res 2:613-618 (Pubitemid 26133464)
10. Eijan AM, Davel K, Rueda H et al (1998) Differential nitric oxide release and sensitivity to injury in different murine mammarytumor cell lines. Int J Mol Med 2:625-630
11. Eijan AM, Piccardo I, Riveros MD et al (2002) Nitric oxide in patients with transitional bladder cancer. J Surg Oncol 81:203-208 (Pubitemid 35397152)
12. Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation more stable ABTS radical cation. Clin Biochem 37:277-285 (Pubitemid 38314881)
13. Gonenc A, Ozkan Y, Torun M, Simsek B (2001) Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther 26:141-144 (Pubitemid 32336730)
14. Guszczyn T, Sobolewski K (2004) Deregulation of collagen metabolism in human stomach cancer. Pathobiology 71:308-313 (Pubitemid 40082310)
15. Jackson SH, Dennis AN, Greenberg MC (1975) Iminodipeptiduria: a genetic defect in recycling collagen; a method for determining prolidase in erythrocytes. Can Med Ass J 113(759):762-763
16. Kaczmarek P, Buczyński A, Niemirowicz J et al (2001) Lipids peroxidation in platelets in patients with bladder cancer treated with Mycobacterium suspension. Pol Merkur Lekarski 11:484-486
17. Kaplan EP, Richier JC, Howard PS, Ewalt DH, Lin VK (1997) Type III collagen messenger RNA is modulated in non-compliant human bladder tissue. J Urol 157:2366-2369 (Pubitemid 27208723)
18. Karna E, Surazynski A, Palka J (2000) Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale. Int J Exp Pathol 81:341-347 (Pubitemid 32061652)
19. Kleiner DE, Stetler-Stevenson WG (1999) Matrix metalloproteinases and metastasis. Cancer Chemother Pharmac 43:42-51
20. Knowles RG, Moncada S (1994) Nitric oxide synthase in mammals. Biochem J 198:249-258
21. Koshland DE Jr (1993) Molecule of the year. Science 262:1953 (Pubitemid 24041867)
22. Liu G, Nakayama K, Awata S et al (2007) Prolidase isoenzymes in the rat: their organ distribution, developmental change and specific inhibitors. Pediatr Res 62:54-59 (Pubitemid 46985850)
23. Macvicar AD (2000) Bladder cancer staging. BJU Int 86:111-122
24. Marnett LJ (2000) Oxyradicals and DNA damage. Carcinogenesis 21:361-370 (Pubitemid 30137921)
25. Mates JM, Perez-Gomez C, de Castro IN (1999) Antioxidant enzymes and human diseases. Clin Biochem 32:595-603 (Pubitemid 30039087)
26. Mei JM, Borchert GL, Donald SP, Phang JM (2002) Matrix metalloproteinase (s) mediate (s) NO-induced dissociation of beta-catenin from membrane bound E-cadherin and formation of nuclear beta-catenin/LEF-1 complex. Carcinogenesis 23:2119-2122 (Pubitemid 36104962)
27. Myara I, Charpentier C, Lemonnier A (1982) Optimal conditions for prolidase assay by proline colorimetric determination: application to imminodipeptiduria. Clin Chim Acta 125:193-205 (Pubitemid 12002380)
28. Myara I, Charpentier C, Lemonnier A (1984) Prolidase and prolidase deficiency. Life Sci 34:1985-1998 (Pubitemid 14145153)
29. Nishikawa M (2008) Reactive oxygen species in tumor metastasis. Cancer Lett 266:53-59
30. O'Byrne KJ, Dalgleish AG (2001) Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 85:473-483 (Pubitemid 32808267)
31. Ozmen H, Erulas FA, Karatas F et al (2006) Comparison of the concentration of trace metals (Ni, Zn, Co, Cu, and Se), Fe, vitamins A, C, and E, and lipid peroxidation in patients with prostate cancer. Clin Chem Lab Med 44:175-179 (Pubitemid 43237961)
32. Palka J, Surazynski A, Karna E et al (2002) Prolidase activity disregulation in chronic pancreatitis and pancreatic cancer. Hepatogastroenterology 49:1699-1703 (Pubitemid 35277361)
33. Sharma A, Rajjapa M, Saxena A et al (2007) Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation. Br J Biomed Sci 64:23-27 (Pubitemid 46952968)
34. Surazynski A, Liu Y, Miltyk W, Phang JM (2005) Nitric oxide regulates prolidase activity by serine/threonine phosphorylation. J Cell Biochem 96(5):1086-1094 (Pubitemid 41693471)
35. Surazynski A, Donald SP, Cooper SK et al (2008a) Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer 122:1435-1440 (Pubitemid 351287248)
36. Surazynski A, Miltyk W, Palka J, Phang JM (2008b) Prolidasedependent regulation of collagen biosynthesis. Amino Acids 35:731-738
37. Tas F, Hansel H, Belce A et al (2005) Oxidative stress in breast cancer. Med Oncol 22:11-15 (Pubitemid 40647224)
38. Templar J, Kon SP, Milligan TP, Newman DJ, Raftery MJ (1999) Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. Nephrol Dial Transplant 14:946-951 (Pubitemid 29155153)
39. Tracey WR, Tse J, Carter G (1995) Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 272:1011-1015
40. Tsuruda T, Costello-Boerrigter LC, Burnett JC Jr (2004) Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail Rev 9:53-61 (Pubitemid 38196077)
41. Wolf H, Haeckel C, Roessner A (2000) Inducible nitric oxide synthase expression in human urinary bladder cancer. Virchows Arch 437:662-666 (Pubitemid 32003098)
42. Wynder EL, Goldsmith R (1977) The epidemiology of bladder cancer: a second look. Cancer 40:1246-1268 (Pubitemid 8219482)
43. Yalcin O, Karatas F, Erulas FA et al (2004) The levels of glutathione peroxidase, vitamins A, E, C, and lipid peroxidation in patients with urothelial carcinoma of the bladder. BJU Int 93:863-866 (Pubitemid 38497044)
44. Yoshimura R, Wada S, Matsuyama M, Hase T, Goto T, Tanaka T, Kuratsukuri K, Tsuchida K, Nakatani T (2004) Urinary extracellular matrix measurement as a reliable and cost effective diagnostic tool for bladder tumors. Int J Mol Med 13(1):127-131
45. Yoshioka T, Kawada K, Shimada T et al (1979) Lipid peroxidation in maternal and cord blood and protective mechanisms against activated oxygen toxicity in the blood. Am J Obster Gynecol 135:372-376 (Pubitemid 9253643)
46. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA (2004) The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 21:392-401